231 related articles for article (PubMed ID: 34249864)
1. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
Ferreira JC; Fadl S; Villanueva AJ; Rabeh WM
Front Chem; 2021; 9():692168. PubMed ID: 34249864
[TBL] [Abstract][Full Text] [Related]
2. pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity.
Al Adem K; Ferreira JC; Fadl S; Rabeh WM
J Biol Chem; 2023 Feb; 299(2):102790. PubMed ID: 36509143
[TBL] [Abstract][Full Text] [Related]
3. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.
Ferreira JC; Fadl S; Ilter M; Pekel H; Rezgui R; Sensoy O; Rabeh WM
FASEB J; 2021 Aug; 35(8):e21774. PubMed ID: 34324734
[TBL] [Abstract][Full Text] [Related]
5. Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs.
Rizzuti B; Grande F; Conforti F; Jimenez-Alesanco A; Ceballos-Laita L; Ortega-Alarcon D; Vega S; Reyburn HT; Abian O; Velazquez-Campoy A
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33918402
[TBL] [Abstract][Full Text] [Related]
6. 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials.
Amorim VMF; Soares EP; Ferrari ASA; Merighi DGS; de Souza RF; Guzzo CR; Souza AS
Viruses; 2024 May; 16(6):. PubMed ID: 38932137
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
8. Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis.
Solowiej J; Thomson JA; Ryan K; Luo C; He M; Lou J; Murray BW
Biochemistry; 2008 Feb; 47(8):2617-30. PubMed ID: 18237196
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2.
Ferreira JC; Rabeh WM
Sci Rep; 2020 Dec; 10(1):22200. PubMed ID: 33335206
[TBL] [Abstract][Full Text] [Related]
10. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.
Huang C; Wei P; Fan K; Liu Y; Lai L
Biochemistry; 2004 Apr; 43(15):4568-74. PubMed ID: 15078103
[TBL] [Abstract][Full Text] [Related]
11. Targeting natural products against SARS-CoV-2.
Al-Harrasi A; Behl T; Upadhyay T; Chigurupati S; Bhatt S; Sehgal A; Bhatia S; Singh S; Sharma N; Vijayabalan S; Palanimuthu VR; Das S; Kaur R; Aleya L; Bungau S
Environ Sci Pollut Res Int; 2022 Jun; 29(28):42404-42432. PubMed ID: 35362883
[TBL] [Abstract][Full Text] [Related]
12. Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2.
Ferreira JC; Fadl S; Rabeh WM
J Biol Chem; 2022 Jun; 298(6):102023. PubMed ID: 35568197
[TBL] [Abstract][Full Text] [Related]
13. Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome.
Prasertsuk K; Prongfa K; Suttiwanich P; Harnkit N; Sangkhawasi M; Promta P; Chumnanpuen P
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615263
[TBL] [Abstract][Full Text] [Related]
14. Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors.
Achutha AS; Pushpa VL; Suchitra S
J Proteome Res; 2020 Nov; 19(11):4706-4717. PubMed ID: 32960061
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease.
Pavlova A; Lynch DL; Daidone I; Zanetti-Polzi L; Smith MD; Chipot C; Kneller DW; Kovalevsky A; Coates L; Golosov AA; Dickson CJ; Velez-Vega C; Duca JS; Vermaas JV; Pang YT; Acharya A; Parks JM; Smith JC; Gumbart JC
bioRxiv; 2020 Sep; ():. PubMed ID: 32935106
[TBL] [Abstract][Full Text] [Related]
16. Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases.
Kumar V; Roy K
SAR QSAR Environ Res; 2020 Jul; 31(7):511-526. PubMed ID: 32543892
[TBL] [Abstract][Full Text] [Related]
17. Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs.
Lin CW; Tsai CH; Tsai FJ; Chen PJ; Lai CC; Wan L; Chiu HH; Lin KH
FEBS Lett; 2004 Sep; 574(1-3):131-7. PubMed ID: 15358553
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease.
Pavlova A; Lynch DL; Daidone I; Zanetti-Polzi L; Smith MD; Chipot C; Kneller DW; Kovalevsky A; Coates L; Golosov AA; Dickson CJ; Velez-Vega C; Duca JS; Vermaas JV; Pang YT; Acharya A; Parks JM; Smith JC; Gumbart JC
Chem Sci; 2021 Jan; 12(4):1513-1527. PubMed ID: 35356437
[TBL] [Abstract][Full Text] [Related]
19. Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors.
Paul A; Sarkar A; Saha S; Maji A; Janah P; Kumar Maity T
Bioorg Med Chem; 2021 Sep; 46():116301. PubMed ID: 34332853
[TBL] [Abstract][Full Text] [Related]
20. Tannins inhibit SARS-CoV-2 through binding with catalytic dyad residues of 3CL
Khalifa I; Zhu W; Mohammed HHH; Dutta K; Li C
J Food Biochem; 2020 Aug; 44(10):e13432. PubMed ID: 32783247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
